Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Mundipharma introduces Remsima (infliximab) in six European countries By PBR Staff Writer
Mundipharma International’s network of independent associated companies are set to introduce a new-generation value-based monoclonal antibody, Remsima (infliximab), this month in six European countries.
Production & Manufacturing > Manufacturing > News
Ireland's Shire buys Meritage Pharma for $70m By PBR Staff Writer
Irish drugmaker Shire has acquired a US-based privately-held company, Meritage Pharma, in a $70m deal that is expected to strengthen its gastrointestinal drugs business.
Production & Manufacturing > Manufacturing > News Novartis agrees to FTC’s conditions to acquire GSK’s oncology drugs By PBR Staff Writer
Novartis has signed an agreement to fulfil the conditions set out by the US Federal Trade Commission (FTC) to move forward with its proposed $16bn acquisition of GlaxoSmithKline’s (GSK) portfolio of cancer-treatment drugs.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Novartis agrees to FTC’s conditions to acquire GSK’s oncology drugs
By PBR Staff Writer
Novartis has signed an agreement to fulfil the conditions set out by the US Federal Trade Commission (FTC) to move forward with its proposed $16bn acquisition of GlaxoSmithKline’s (GSK) portfolio of cancer-treatment drugs.
Production & Manufacturing > Manufacturing > News
Valeant to buy Salix Pharmaceuticals for $14.5bn
By PBR Staff Writer
Canada-based Valeant Pharmaceuticals International has signed an agreement to acquire all of the outstanding common stock of Salix Pharmaceuticals for approximately $14.5bn.
Production & Manufacturing > Manufacturing > News
Kite expands manufacturing capabilities for CAR and TCR cancer immunotherapy products
By PBR Staff Writer
US-based clinical-stage biopharmaceutical firm Kite Pharma has entered into a lease agreement for a commercial manufacturing facility in El Segundo, California, for the devlopment of new cancer immunotherapy products.
Production & Manufacturing > Manufacturing > News
Particle Sciences produces clinical supplies for Kinex's KX2-361 to treat glioblastoma
By PBR Staff Writer
Particle Sciences (PSI) has completed the manufacturing of clinical supplies for the first in human studies of Kinex Pharmaceuticals' small molecule Src/pre-tublin inhibitor, KX2-361 (KX02), to treat glioblastoma.
Production & Manufacturing > Manufacturing > News
Galderma makes Soolantra Cream, 1% available in US for rosacea patients
By PBR Staff Writer
Galderma Laboratories has launched Soolantra (ivermectin) Cream, 1% , a once-daily, antibiotic-free, prescription topical treatment for rosacea patients in the US.
Production & Manufacturing > Manufacturing > News
FeF Chemicals A/S to Change to Novo Nordisk Pharmatech A/S and makes the Transfer to SAP
Fef Chemicals A/S has confirmed that it will change its name to Novo Nordisk Pharmatech A/S as of September 1st 2015.
Production & Manufacturing > Manufacturing > Press Releases
Lonza to manufacture Cx601 product for TiGenix's Phase III trial in US
By PBR Staff Writer
Swiss development and manufacturing firm Lonz has entered into an agreement for the supply of Belgian biopharmaceutical firm TiGenix's eASC product, Cx601, indicated to treat complex perianal fistulas in Crohn's disease patients.
Production & Manufacturing > Manufacturing > News
Cumberland begins Phase II clinical development program of Boxaban to treat AERD
By PBR Staff Writer
US-based Cumberland Pharmaceuticals has started a Phase II clinical development program of Boxaban (ifetroban), an active thromboxane receptor antagonist, to treat aspirin-exacerbated respiratory disease (AERD).
Production & Manufacturing > Manufacturing > News
Enteris launches contract manufacturing within 32,000ft² FDA inspected and cGMP compliant facility
Enteris BioPharma, an industry leader in oral peptide delivery, announced the launch of contract manufacturing located within its 32,000 square foot, FDA inspected and cGMP compliant facility in Boonton, New Jersey.
Production & Manufacturing > Manufacturing > News
Julphar acquires majority stake in RAK Pharmaceuticals for $9.5m
Julphar, the largest Emirati pharmaceutical company, has acquired a majority stake in Bangladesh Company RAK Pharmaceuticals, marking its entry into the region and an expansion of its footprint in Asia.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250